Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 502544123

PD-L1 (Atezolizumab) Recombinant Human Monoclonal Antibody (Atezolizumab), Functional Grade, Fc Muted™, Leinco Technologies™
SDP

Catalog No. 502544123
Encompass
Encompass_Preferred
Change view
Click to view available options
Quantity:
500 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
50-254-4123 500 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 50-254-4123 Supplier Leinco Technologies Inc Supplier No. LT1755500UG
Add to Cart
Add to Cart

Description

Human Recombinant Monoclonal Antibody

Specificity: This non-therapeutic biosimilar antibody uses the same variable region sequence as the therapeutic antibody Atezolizumab. Atezolizumab recognizes an epitope on mouse PD-L1. Endotoxin Level: <1.0 EU/mg as determined by the LAL method. Purity: ≥95% monomer by analytical SEC. Preparation: Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. Pathogen Testing: To protect mouse colonies from infection by pathogens and to assure that experimental preclinical data is not affected by such pathogens, all of Leinco recombinant biosimilar antibodies are tested and guaranteed to be negative for all pathogens in the IDEXX IMPACT I Mouse Profile. Storage: Functional grade biosimilar antibodies may be stored sterile as received at 2-8C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80C. Avoid Repeated Freeze Thaw Cycles.

PD-L1 (Atezolizumab) Recombinant Monoclonal antibody specifically detects PD-L1 (Atezolizumab) in Human samples. It is validated for Flow Cytometry, Western Blot

Specifications

Antigen PD-L1 (Atezolizumab)
Applications Flow Cytometry, Western Blot
Classification Recombinant Monoclonal
Clone Atezolizumab
Concentration ≥5.0 mg/mL
Conjugate Functional Grade
Formulation PBS with no preservative; pH 7.2-7.4
Gene Alias MPDL3280A; RG7446; Tecentriq
Host Species Human
Immunogen Recombinant extracellular domain-Fc fusion of human PD-L1R
Purification Method Protein A/G
Quantity 500 μg
Regulatory Status RUO
Primary or Secondary Primary
Target Species Human
Content And Storage 4°C short term, -80°C long term
Product Type Antibody
Form Liquid
Isotype IgG
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.